Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
BETA v.3.0

2025 HCPCS code G0433

This HCPCS code represents an enzyme-linked immunosorbent assay (ELISA) test for HIV-1 and/or HIV-2 antibody screening.

Follow all payer-specific guidelines.Ensure proper modifier usage (QW for CLIA waived tests) and appropriate accompanying ICD codes for billing. Adhere to HIPAA regulations concerning patient privacy and PHI.

Modifiers may apply depending on the specific circumstances, including the location of service, the type of test performed (rapid or conventional), and the payer's requirements.Refer to the specific payer's guidelines.

Medical necessity for HIV screening is established based on patient risk factors (e.g., sexual history, intravenous drug use, exposure to HIV), pregnancy, or as part of routine preventative care in high-risk populations.Specific criteria may vary by payer.

The clinical responsibility lies with the healthcare provider who orders and interprets the test results.This includes collecting the sample (usually blood), performing or sending the test to a lab, and counseling the patient on the results and next steps, especially if the screening test is positive.

IMPORTANT:Related codes include G0432 (EIA) and G0435 (rapid oral fluid test).Note that appropriate modifiers (e.g., QW for CLIA-waived tests) may be required depending on payer and testing methodology.

In simple words: This code is for a blood test that checks if you have antibodies to HIV (the virus that causes AIDS).A positive result means further tests are needed to confirm if you have HIV.

G0433 is an HCPCS code billing for infectious agent antibody detection using the enzyme-linked immunosorbent assay (ELISA) technique to screen for HIV-1 and/or HIV-2 antibodies.The test involves detecting antibodies produced by the body in response to HIV infection. A positive screening result necessitates confirmatory testing to confirm HIV infection.This code is specifically for screening purposes and does not encompass confirmatory testing.The test typically uses a blood sample, and the ELISA method involves detecting a biochemical color change indicating the presence of antibodies.

Example 1: A patient presents to their primary care physician expressing concerns about potential HIV exposure. The physician orders an HIV ELISA screening test (G0433) as part of a routine checkup. The test is performed at an outside laboratory., A pregnant woman undergoes routine prenatal testing, including an HIV screening test (G0433).The test is conducted at a CLIA-waived laboratory using a rapid test, requiring the QW modifier., An individual seeks testing at a community health clinic. The clinic uses a CLIA-waived ELISA HIV test (G0433), and the results are discussed with a counselor to support the patient in managing their healthcare.

Patient demographics, reason for ordering the test (risk factors, exposure history, pregnancy), date and time of specimen collection, test results, provider's interpretation and counseling provided, and CLIA waiver information if applicable.

** Always consult the most up-to-date payer guidelines for specific billing requirements, including coding, modifier application, and coverage policies.Confirm compliance with CLIA regulations.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.

Discover what matters.

iFrame™ AI's knowledge is aligned with and limited to the materials uploaded by users and should not be interpreted as medical, legal, or any other form of advice by iFrame™.